Novabridge Biosciences ADR
(NBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | N/A | -208,560 | N/A |
| Depreciation Amortization | N/A | 2,246 | N/A |
| Other Working Capital | N/A | 26,544 | N/A |
| Other Operating Activity | 0 | 55,092 | 0 |
| Operating Cash Flow | $N/A | $-124,678 | $N/A |
| Cash Flows From Investing Activities | |||
| Other Investing Activity | 0 | 30,518 | 0 |
| Investing Cash Flow | $N/A | $30,518 | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 0 | 21,936 | 0 |
| Financing Cash Flow | $N/A | $21,936 | $N/A |
| Exchange Rate Effect | N/A | 2,178 | N/A |
| Beginning Cash Position | N/A | 241,451 | N/A |
| End Cash Position | N/A | 171,405 | N/A |
| Net Cash Flow | $N/A | $-70,046 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | N/A | -124,678 | N/A |
| Free Cash Flow | 0 | -124,678 | 0 |